Company News for March 16, 2010

• UBS (NYSE:UBS) upgraded Starbucks (NASDAQ:SBUX) to "buy" from "neutral” with a $29 price target

• Goldman Sachs (NYSE:GS) upgraded Coventry Health Care (NYSE:CVH) to "neutral" and removed the shares from its Conviction Sell List, noting in-line valuation levels

• Piper Jaffray (NYSE:PJC) upgraded Sonic (NASDAQ:SONC) to "overweight" from "underweight," raising the price target to $12 from $8

• Goldman Sachs (NYSE:GS) upgraded Onyx Pharmaceuticals (NASDAQ:ONXX) to "buy" from "neutral," taking the price target to $37 from $34

• Citigroup (NYSE:C) upgraded Wal-Mart (NYSE:WMT) shares, with its price target raised to $65

• Goldman Sachs (NYSE:GS) moved Boston Scientific (NYSE:BSX) to its Conviction Sell List, downgrading the shares from "neutral" to "sell." Yesterday Boston Scientific shares fell 12.6% on news of its plans to pull certain defibrillator models from the market

• After the market closed, Limited Brands (NYSE:LTD) announced plans to pay a special dividend of $1 per share, as well as its approval of a new $200 million share buyback, which includes $31 million of the previous plan

• Discover (NYSE:DFS) is due to report fiscal first quarter earnings after the close today. Analysts expect the company to report a 12 cent profit, up from last year's 36 cent loss

Read the full analyst report on UBS

Read the full analyst report on SBUX

Read the full analyst report on GS

Read the full analyst report on CVH

Read the full analyst report on PJC

Read the full analyst report on SONC

Read the full analyst report on ONXX

Read the full analyst report on C

Read the full analyst report on WMT

Read the full analyst report on BSX

Read the full analyst report on LTD

Read the full analyst report on DFS